A detailed history of Deutsche Bank Ag\ transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 67,010 shares of HRMY stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,010
Previous 45,282 47.98%
Holding current value
$2.2 Million
Previous $1.37 Million 95.97%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.0 - $39.95 $651,840 - $868,033
21,728 Added 47.98%
67,010 $2.68 Million
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $125,409 - $143,692
-4,353 Reduced 8.77%
45,282 $1.37 Million
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $965,302 - $1.13 Million
-32,252 Reduced 39.39%
49,635 $1.67 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $1.26 Million - $2.21 Million
65,420 Added 397.28%
81,887 $2.64 Million
Q3 2023

Nov 09, 2023

SELL
$31.89 - $39.03 $1.85 Million - $2.26 Million
-58,008 Reduced 77.89%
16,467 $539,000
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $802,546 - $984,106
26,313 Added 54.63%
74,475 $2.62 Million
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $2.32 Million - $4.06 Million
-75,266 Reduced 60.98%
48,162 $1.57 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $3.63 Million - $4.86 Million
79,862 Added 183.31%
123,428 $6.8 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.28 Million - $1.68 Million
30,352 Added 229.7%
43,566 $1.93 Million
Q2 2022

Aug 11, 2022

SELL
$33.54 - $52.15 $1,811 - $2,816
-54 Reduced 0.41%
13,214 $645,000
Q1 2022

May 13, 2022

SELL
$33.14 - $51.13 $41,193 - $63,554
-1,243 Reduced 8.57%
13,268 $645,000
Q4 2021

Feb 11, 2022

SELL
$34.09 - $43.91 $2.62 Million - $3.38 Million
-76,865 Reduced 84.12%
14,511 $618,000
Q3 2021

Nov 04, 2021

BUY
$25.68 - $38.61 $211,988 - $318,725
8,255 Added 9.93%
91,376 $3.5 Million
Q2 2021

Aug 11, 2021

BUY
$25.96 - $33.44 $2.05 Million - $2.65 Million
79,142 Added 1988.99%
83,121 $2.35 Million
Q1 2021

May 13, 2021

SELL
$27.56 - $40.37 $10,417 - $15,259
-378 Reduced 8.68%
3,979 $131,000
Q4 2020

Feb 16, 2021

BUY
$31.74 - $51.34 $138,291 - $223,688
4,357 New
4,357 $158,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.